Ticker > Company >

Zenith Health Care share price

Zenith Health Care Ltd.

BSE: 530665 SECTOR: Pharmaceuticals & Drugs  38.18 K   211   25

4.26
-0.01 (-0.23%)
BSE: 29 Aug 04:01 PM

Price Summary

Today's High

₹ 4.4

Today's Low

₹ 4.17

52 Week High

₹ 6.87

52 Week Low

₹ 3.33

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

22.89 Cr.

Enterprise Value

20.35 Cr.

No. of Shares

5.37 Cr.

P/E

0

P/B

3.1

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  1.37

CASH

2.55 Cr.

DEBT

0 Cr.

Promoter Holding

28.74 %

EPS (TTM)

₹  -0.02

Sales Growth

10.22%

ROE

2.79 %

ROCE

3.97%

Profit Growth

161.57 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year10.22%
3 Year1.74%
5 Year8.04%

Profit Growth

1 Year161.57%
3 Year-22.66%
5 Year8.31%

ROE%

1 Year2.79%
3 Year2.77%
5 Year4.85%

ROCE %

1 Year3.97%
3 Year4.85%
5 Year6.56%

Debt/Equity

0

Price to Cash Flow

13.19

Interest Cover Ratio

21.1314

CFO/PAT (5 Yr. Avg.)

1.63811513627518

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 28.74 0.00
Mar 2025 28.74 0.00
Dec 2024 28.74 0.00
Sep 2024 28.74 0.00
Jun 2024 28.74 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 77.4083 days.
  • Company has a healthy liquidity position with current ratio of 3.0322.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.95968509867822.

 Limitations

  • The company has shown a poor profit growth of -22.6629697370388% for the Past 3 years.
  • The company has shown a poor revenue growth of 1.74474396030966% for the Past 3 years.
  • Company has a poor ROE of 2.77093613386952% over the past 3 years.
  • Company has a poor ROCE of 4.85474702970168% over the past 3 years
  • The company has a low EBITDA margin of 2.13210213993276% over the past 5 years.
  • The company is trading at a high PE of 0.
  • The company is trading at a high EV/EBITDA of 55.8303.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 2.57 3.03 2.31 3.43 3.15
Total Expenditure 2.45 2.88 2.5 3.4 3.28
Operating Profit 0.12 0.15 -0.2 0.03 -0.13
Other Income 0.08 0.08 0.16 0.11 0.17
Interest 0 0 0 0 0
Depreciation 0.04 0.04 0.07 0.08 0.06
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.16 0.18 -0.11 0.05 -0.03
Tax 0 0.09 0.18 -0.06 -0.01
Profit After Tax 0.16 0.1 -0.29 0.11 -0.02
Adjusted EPS (Rs) 0.03 0.02 -0.05 0.02 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 11.98 13.74 22.36 13.13 14.47
Total Expenditure 11.43 13.43 21.9 13.1 14.24
Operating Profit 0.55 0.31 0.46 0.03 0.23
Other Income 0.3 0.5 0.52 0.38 0.27
Interest 0.01 0.01 0.01 0.01 0.01
Depreciation 0.25 0.25 0.36 0.28 0.21
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.58 0.56 0.61 0.12 0.28
Tax 0.02 0.12 0.3 0.04 0.07
Net Profit 0.57 0.44 0.31 0.08 0.2
Adjusted EPS (Rs.) 0.11 0.08 0.06 0.01 0.04

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.37 5.37 5.37 5.37 5.37
Total Reserves 1.03 1.47 1.78 1.86 1.96
Borrowings 0 0 0 0 0
Other N/C liabilities -0.31 -0.32 -0.12 -0.11 -0.11
Current liabilities 2.14 1.92 4.51 2.02 2.4
Total Liabilities 8.23 8.44 11.55 9.13 9.63
Assets
Net Block 1.7 1.8 1.75 1.5 1.4
Capital WIP 0.17 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.22 0.26 0.29 0.4 0.11
Other N/C Assets 0 0 0 0.09 0.83
Current Assets 6.15 6.38 9.5 7.14 7.29
Total Assets 8.23 8.44 11.55 9.13 9.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.61 0.59 0.61 0.12 0.28
Adjustment 0.26 0.26 0.37 0.29 0.22
Changes in Assets & Liabilities 1.1 -2.14 0.53 -1.29 1.42
Tax Paid -0.01 -0.16 -0.18 -0.03 -0.17
Operating Cash Flow 1.95 -1.47 1.32 -0.92 1.74
Investing Cash Flow -0.5 -0.19 -0.23 -0.03 -0.11
Financing Cash Flow -0.02 0 0 0 0
Net Cash Flow 1.44 -1.65 1.09 -0.95 1.63

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 28.74 28.74 28.74 28.74 28.74
ashwin m. thakker 0.01 0.01 0.01 0.01 0.01
mahendra chatrabhuj ray... 12.29 12.29 12.29 12.29 12.29
mahendra chatrabhujbhai ... 9.55 9.55 9.55 9.55 9.55
neela mahendra raycha 2.35 2.35 2.35 2.35 2.35
ray remedies pvt. ltd. 0.48 0.48 0.48 0.48 0.48
raycha akshit mahendra 0.35 0.35 0.35 0.35 0.35
zenith life care private ... 3.72 3.72 3.72 3.72 3.72
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 71.26 71.26 71.26 71.26 71.26
harsha jhaveri 2.19 2.19 2.19 2.19 2.19
sharpline trading co. pvt... 3.29 3.29 3.29 3.29 3.29

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Zenith Health Care - Quaterly Results 12 Aug, 2:50 PM Zenith Health Care - Quaterly Results 12 Aug, 2:50 PM Zenith Health Care - Quaterly Results 12 Aug, 2:50 PM Zenith Health Care - Quaterly Results 27 May, 5:24 PM Zenith Health Care - Quaterly Results 27 May, 5:24 PM Zenith Health Care - Quaterly Results 11 Feb, 4:04 PM Zenith Health Care - Quaterly Results 11 Feb, 4:04 PM Zenith Health Care - Quaterly Results 11 Feb, 4:04 PM Zenith Health Care - Quaterly Results 24 Oct, 6:02 PM Zenith Health Care - Quaterly Results 24 Oct, 6:02 PM Zenith Health Care informs about outcome of AGM 26 Aug, 12:44 PM Zenith Health Care informs about press release 2 Aug, 5:23 PM Zenith Healthcare informs about board meeting 23 Jul, 5:14 PM Zenith Health Care - Quaterly Results 20 Jul, 12:40 PM Zenith Health Care - Quaterly Results 20 Jul, 12:40 PM Zenith Health Care - Quaterly Results 20 Jul, 12:40 PM Zenith Health Care - Quaterly Results 12 Feb, 5:34 PM Zenith Health Care - Quaterly Results 12 Feb, 5:34 PM Zenith Health Care - Quaterly Results 6 Nov, 4:21 PM Zenith Health Care - Quaterly Results 6 Nov, 4:21 PM Zenith Health Care - Quaterly Results 6 Nov, 4:21 PM Zenith Health Care - Quaterly Results 13 Feb, 5:23 PM Zenith Health Care informs about confirmation certificate 12 Oct, 5:17 PM Zenith Healthcare informs about non-applicability of large corporate entity 16 Apr, 2:54 PM Zenith Healthcare informs about certificate 8 Apr, 2:56 PM Zenith Health Care - Quaterly Results 11 Feb, 5:19 PM Zenith Healthcare informs about re-appoinment of MD 29 Sep, 1:39 PM

Zenith Health Care Stock Price Analysis and Quick Research Report. Is Zenith Health Care an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Zenith Health Care. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zenith Health Care has a PE ratio of -211.940298507463 which is low and comparatively undervalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zenith Health Care has ROA of 2.169% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zenith Health Care has a Current ratio of 3.0322.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zenith Health Care has a ROE of 2.7934%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Zenith Health Care has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: Zenith Health Care has reported revenue growth of 10.2236% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Zenith Health Care for the current financial year is 1.5851627659501%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zenith Health Care is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Zenith Health Care is Rs -0.0201. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Zenith Health Care in Ticker for free. Also, one can get the intrinsic value of Zenith Health Care by using Valuation Calculators, which are available with a Finology ONE subscription. 

Zenith Health Care FAQs

Q1. What is Zenith Health Care share price today?
Ans: The current share price of Zenith Health Care is Rs 4.26.

Q2. What is the market capitalisation of Zenith Health Care?
Ans: Zenith Health Care has a market capitalisation of Rs 22.892814 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Zenith Health Care?
Ans: The PE ratio of Zenith Health Care is -211.940298507463 and the P/B ratio of Zenith Health Care is 3.09953434225844, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Zenith Health Care share?
Ans: The 52-week high share price of Zenith Health Care is Rs 6.87, and the 52-week low share price of Zenith Health Care is Rs 3.33.

Q5. Does Zenith Health Care pay dividends?
Ans: Currently, Zenith Health Care does not pay dividends. Dividend yield of Zenith Health Care is around 0%.

Q6. What are the face value and book value of Zenith Health Care shares?
Ans: The face value of Zenith Health Care shares is Rs 1, while the book value per share of Zenith Health Care is around Rs 1.3744. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Zenith Health Care?
Ans: Zenith Health Care has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Zenith Health Care?
Ans: The ROE of Zenith Health Care is 2.7934% and ROCE of Zenith Health Care is 3.9739%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Zenith Health Care a good buy for the long term?
Ans: The Zenith Health Care long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Zenith Health Care undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Zenith Health Care appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Zenith Health Care’s financials?
Ans: You can review Zenith Health Care’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Zenith Health Care
X